Inventor
FOWLKES DANA M
US29 patents
⚠️ This page may combine multiple inventors who share the name “FOWLKES DANA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NORTH CAROLINA
14 patentsUS5498538AMar 12, 1996
Totally synthetic affinity reagents
UNIV NORTH CAROLINA205 citations99
US5747334AMay 5, 1998
Random peptide library
UNIV NORTH CAROLINA101 citations97
US5948635ASep 7, 1999
Totally Synthetic Affinity Reagents
UNIV NORTH CAROLINA49 citations95
US6184205B1Feb 6, 2001
GRB2 SH3 binding peptides and methods of isolating and using same
UNIV NORTH CAROLINA63 citations93
US5935823AAug 10, 1999
Totally synthetic affinity reagents
UNIV NORTH CAROLINA33 citations92
US5625033AApr 29, 1997
Totally synthetic affinity reagents
UNIV NORTH CAROLINA27 citations92
US6309820B1Oct 30, 2001
Polypeptides having a functional domain of interest and methods of identifying and using same
UNIV NORTH CAROLINA19 citations90
US5844076ADec 1, 1998
Totally synthetic affinity reagents
UNIV NORTH CAROLINA5 citations74
US5338833AAug 16, 1994
Carboxy terminal IL-6 muteins
UNIV NORTH CAROLINA7 citations74
US7279548B2Oct 9, 2007
Identification and isolation of novel polypeptides having WW domains and methods of using same
UNIV NORTH CAROLINA7 citations71
US6011137AJan 4, 2000
Identification and isolation of novel polypeptides having WW domains and methods of using same
UNIV NORTH CAROLINA11 citations71
US5565336AOct 15, 1996
Carboxy terminal IL-6 muteins
UNIV NORTH CAROLINA1 citations52
US7223547B2May 29, 2007
Polypeptides having a functional domain of interest and methods of identifying and using same
UNIV NORTH CAROLINA1 citations49
US6709821B2Mar 23, 2004
Polypeptides having a functional domain of interest and methods of identifying and using same
UNIV NORTH CAROLINA0 citations49
CADUS TECHNOLOGIES INC
8 patentsUS6864060B1Mar 8, 2005
Yeast cells expressing modified G proteins and methods of use therefor
CADUS TECHNOLOGIES INC21 citations90
US7122305B2Oct 17, 2006
Methods and compositions for identifying receptor effectors
CADUS TECHNOLOGIES INC7 citations72
US7361498B2Apr 22, 2008
Yeast cells expressing modified G proteins and methods of use therefor
CADUS TECHNOLOGIES INC5 citations71
US7611854B2Nov 3, 2009
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
CADUS TECHNOLOGIES INC4 citations62
US7416881B1Aug 26, 2008
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
CADUS TECHNOLOGIES INC4 citations62
US7235648B1Jun 26, 2007
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
CADUS TECHNOLOGIES INC5 citations62
US7250263B2Jul 31, 2007
Methods and compositions for identifying receptor effectors
CADUS TECHNOLOGIES INC4 citations60
US7105309B2Sep 12, 2006
Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
CADUS TECHNOLOGIES INC4 citations60
CADUS PHARMACEUTICAL CORP
3 patentsUS5789184AAug 4, 1998
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
CADUS PHARMACEUTICAL CORP59 citations95
US6255059B1Jul 3, 2001
Methods for identifying G protein coupled receptor effectors
CADUS PHARMACEUTICAL CORP57 citations94
US5876951AMar 2, 1999
Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
CADUS PHARMACEUTICAL CORP41 citations91